Laparoscopic Anterior Esophageal Myotomy and Toupet Fundoplication for Achalasia

Heniford, B. Todd; Matthews, Brent D.; Kercher, Kent W.; Goldstein, Sharon L.; Greer, Steven F.; Sing, Ronald F.; Yavorski, Robert; Deal, Steven E.; Paccico, Thomas; Colvin, Anthony; Cyzner, Ronnie; Drake, Sam
November 2001
American Surgeon;Nov2001, Vol. 67 Issue 11, p1059
Academic Journal
Achalasia is an esophageal motility disorder characterized by the failure of lower esophageal sphincter relaxation and the absence of esophageal peristalsis. The purpose of this study was to evaluate the clinical outcomes of patients undergoing laparoscopic esophageal myotomy and Toupet fundoplication for achalasia. A 9-cm myotomy was performed in most cases extending 7 cm above and 2 cm below the gastroesophageal junction. Severity of dysphagia, heartburn, chest pain, and regurgitation was graded preoperatively and postoperatively using a five-point symptomatic scale (0-4). Patients also graded their outcomes as excellent, good, fair, or poor. Between December 1995 and November 2000 a total of 49 patients (23 male, 26 female) with a mean age of 44.3 years (range 23-71 years) were diagnosed with achalasia. Mean duration of symptoms was 40.2 months (range 4-240 months). Thirty-seven patients (76%) had had a previous nonsurgical intervention or combinations of nonsurgical interventions [pneumatic dilation (23), bougie dilation (five), and botulinum toxin (19)], and two patients had failed esophageal myotomies. Forty-five patients underwent laparoscopic esophageal myotomy and Toupet fundoplication. Two patients received laparoscopic esophageal myotomies without an antireflux procedure, and two were converted to open surgery. One patient presented 10 hours after a pneumatically induced perforation and underwent a successful laparoscopic esophageal myotomy and partial fundoplication. Mean operative time was 180.5 minutes (range 145-264 minutes). Mean length of stay was 1.98 days (range 1-18 days). There were five (10%) perioperative complications but no esophageal leaks. There was a significant difference (P < 0.05) between the preoperative and postoperative dysphagia, chest pain, and regurgitation symptom scores. All patients stated that they were improved postoperatively. Eighty-six per cent rated their outcome as excellent, 10 per cent as good, and 4 per ce...


Related Articles

  • Does illness severity matter? A comparison of laparoscopic esophagomyotomy with fundoplication and esophageal dilation for achalasia. Reynoso, Jason F.; Tiwari, Manish M.; Tsang, Albert W.; Oleynikov, Dmitry // Surgical Endoscopy;May2011, Vol. 25 Issue 5, p1466 

    Introduction: There is scarce evidence regarding optimal treatment options for achalasia in patients with varying illness severity risk. The objective of this study was to evaluate and compare outcomes with laparoscopic esophagomyotomy with fundoplication (LM) and esophageal dilation (ED) for...

  • Tales from previous times: important eponyms in pediatric surgery. Berger, Michael; Muensterer, Oliver; Harmon, Carroll // Pediatric Surgery International;Jan2014, Vol. 30 Issue 1, p1 

    The use of eponyms in medicine has a long and captivating tradition, which applies to pediatric surgery as well. Unfortunately, even though these eponyms are widely used, oftentimes the fascinating personalities and lives behind these names remain unrecognized or underappreciated, especially...

  • Malignant Esophagopulmonary Fistula Complicating Achalasia. Frank, Michael S.; Brandt, Lawrence J.; Haas, Kenneth; Parker, Julius G. // American Journal of Gastroenterology;Feb1979, Vol. 71 Issue 2, p206 

    Presents a case analysis of a patient who presented with malignant esophagopulmonary fistula complicating achalasia. Medical history of the patient; Treatment management approaches administered to the patient; Details of the endoscopic diagnosis conducted to the patient.

  • A Comparison of Rectal Suction and Full Wall Biopsy in Hirschsprung's Disease. Örnö Ax, Sofie; Arnbjörnsson, E.; Gisselsson-Nord, D. // Surgical Science;Jan2014, Vol. 5 Issue 1, p15 

    Introduction: Hirschsprung's disease (HD) is defined as congenital agangliosis of the colon wall from the rectum extending cranially. There are several radiologic methods for screening for HD but it is a biopsy of the colon wall that confirms the diagnosis. Initially the full wall (FW) biopsy...

  • Meta-Analysis of Randomized and Controlled Treatment Trials for Achalasia. Lan Wang; You-Ming Li; Lan Li // Digestive Diseases & Sciences;Nov2009, Vol. 54 Issue 11, p2303 

    Pharmacological therapy, botulinum toxin injection, pneumatic dilatation, and surgical myotomy are the primary therapeutic modalities for achalasia, for which laparoscopic myotomy is recommended as state-of-the-art therapy. However, its efficacy and safety remain unclear compared with other...

  • YenidoÄŸanda gastrointestinal sistem obstrüksiyonları-II. Tekant, Gonca Topuzlu // Turkish Pediatrics Archive / Turk Pediatri Arsivi;jun2010 supplement, Vol. 45, p38 

    In this study, clinical signs, diagnosis and treatment methods of diseases leading to gastrointestinal obstruction in the newborn period involving hypertrophic pyloric stenosis, malrotation and Hirschsprung's disease are reviewed.

  • Defining the Transition Zone of Hirschsprung Disease. COLLINS, MARGARET H.; REYES-MÛGICA, MIGUEL // Pediatric & Developmental Pathology;Jul/Aug2013, Vol. 16 Issue 4, p235 

    The authors focus on the hirschsprung disease (HSCR) and its treatment using surgical therapy. They relate the study by R. Kapur and A. Kennedy which defines the transition zone of HSCR specimens from patients younger that six months of age during surgery. They note that the study is important...

  • Hirschsprung's disease: 13 years' experience in 112 patients from a single institution. Pini Prato, Alessio; Gentilino, Valerio; Giunta, Camilla; Avanzini, Stefano; Parodi, Stefano; Mattioli, Girolamo; Martucciello, Giuseppe; Jasonni, Vincenzo // Pediatric Surgery International;Feb2008, Vol. 24 Issue 2, p175 

    Although Hirschsprung's disease is curable, a low mortality and a certain morbidity have been described by several authors. We will present our experience with the treatment of Hirschsprung's disease at Gaslini Children's Hospital. All patients who underwent a pull-through procedure since...

  • Transplanting the enteric nervous system: a step closer to treatment for aganglionosis. Gershon, Michael D. // Gut;Apr2007, Vol. 56 Issue 4, p459 

    The article comments on a study by S. Almond and colleagues on major problems that must be overcome before enteric neural crest-derived stem cells can be successfully used to treat Hirschsprung's disease. The researchers note that the crest-derived stem cells have to be isolated and then...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics